Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a-Reference-Cited by-同舟云学术

Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a

Published:2008-03-12 Issue:4 Volume:28 Page:477-485
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:

Author:

Marcellin Patrick,Lau George K. K.,Zeuzem Stefan,Heathcote E. Jenny,Pockros Paul J.,Reddy K. Rajender,Piratvisuth Teerha,Farci Patrizia,Chow Wan-Cheng,Jia Ji-Dong,Paik Woon,Wintfeld Neil,Pluck Nigel

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2008.01696.x/fullpdf

Reference30 articles.

1. World Health Organization http://www.who.int/mediacentre/factsheets/fs164/en/

2. Viral hepatitis B;Lai;Lancet,2003

3. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group;Bonkovsky;Hepatology,1999

5. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis;Foster;Hepatology,1998

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Categorization of patients with systemic lupus erythematosus using disease activity, patient-reported outcomes, and transcriptomic signatures;Clinical Rheumatology;2023-02-10

2. Validation of the Brazilian version of the hepatitis B quality of life evaluation instrument - HBQOL, and its application to patients with chronic hepatitis B in Cascavel - PR;Brazilian Journal of Pharmaceutical Sciences;2022

3. Chronic Hepatitis B Virus Infection: Interferon Therapy and Long-Term Outcomes;Hepatitis B Virus and Liver Disease;2021

4. Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis B;Vaccines;2020-05-11

5. Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus;Rheumatology;2019-11-27